CDK9 anticorps (AA 251-278)
Aperçu rapide pour CDK9 anticorps (AA 251-278) (ABIN3030623)
Antigène
Voir toutes CDK9 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 251-278
-
Réactivité croisée (Details)
- Expected species reactivity: Bovine
-
Purification
- Antigen affinity purified
-
Immunogène
- A portion of amino acids 251-278 from the mouse protein was used as the immunogen for this Cdk9 antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- Titration of the Cdk9 antibody may be required due to differences in protocols and secondary/substrate sensitivity.\. Western blot: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Aliquot the Cdk9 antibody and store frozen at -20°C or colder. Avoid repeated freeze-thaw cycles.
-
-
- CDK9 (Cyclin-Dependent Kinase 9 (CDK9))
-
Autre désignation
- Cdk9
-
Sujet
- Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to production elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II), SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase activity toward CTD of RNAP II and can substitute for P-TEFb in vitro (By similarity).
-
UniProt
- Q99J95
-
Pathways
- Cycle Cellulaire
Antigène
-